Literature DB >> 2372766

Sex steroid receptors in intracranial tumors.

R Romić Stojković1, M Jovancević, D J Santel, N Grcević, S Gamulin.   

Abstract

Estrogen (ER), progestin (PGR), and androgen (AR) receptors were assayed in cytosols prepared from 38 various intracranial tumors. The receptors were in the following proportions (number of receptor-positive/number of tumors examined): meningiomas were positive for PGR (4/6) and AR (2/5); glioblastomas were also positive for PGR (3/21) and AR (7/21); astrocytomas were positive only for PGR (4/5); and oligodendrogliomas only for AR. In two hamartomas AR was present, while in one chordoma both PGR and AR were present. In this latter tumor ER were not assayed due to insufficient material. The receptors were present in concentrations between 10 and 20 fmol/mg protein. Exceptions were two meningiomas and a chordoma with a high concentration of PGR and AR. Our results support the notion that a proportion of intracranial tumors contains sex steroid receptors, and some of these tumors might be hormonally dependent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372766     DOI: 10.1002/1097-0142(19900501)65:9<1968::aid-cncr2820650915>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Surgery, tamoxifen, carboplatin, and radiotherapy in the treatment of newly diagnosed glioblastoma patients.

Authors:  M J Puchner; H D Herrmann; J Berger; L Cristante
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

2.  Gliomatosis cerebri and pituitary adenoma: case report and literature review.

Authors:  A Mangiola; P De Bonis; M Guerriero; A Pompucci; C Anile
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  Progesterone receptor isoforms expression pattern in human chordomas.

Authors:  I Camacho-Arroyo; G González-Agüero; A Gamboa-Domínguez; M A Cerbón; R Ondarza
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

4.  Estrogen receptors in prolactinomas: a clinico-pathological study.

Authors:  G J Kaptain; N E Simmons; T D Alden; M B Lopes; M L Vance; E R Laws
Journal:  Pituitary       Date:  1999       Impact factor: 4.107

5.  Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases.

Authors:  G Zamboni; F Bonetti; A Scarpa; G Pelosi; C Doglioni; A Iannucci; P Castelli; G Balercia; D Aldovini; A Bellomi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.

Authors:  J I Kuratsu; H Seto; M Kochi; Y Ushio
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells.

Authors:  Cheppail Ramachandran; Ziad Khatib; Athena Petkarou; John Fort; Hugo B Fonseca; Steven J Melnick; Enrique Escalon
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States).

Authors:  K P Cantor; C F Lynch; D Johnson
Journal:  Cancer Causes Control       Date:  1993-11       Impact factor: 2.506

Review 9.  Impact of sex in the prevalence and progression of glioblastomas: the role of gonadal steroid hormones.

Authors:  Claudia Bello-Alvarez; Ignacio Camacho-Arroyo
Journal:  Biol Sex Differ       Date:  2021-03-22       Impact factor: 5.027

10.  Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma.

Authors:  Nan Zhao; Fei Wang; Shaheen Ahmed; Kan Liu; Chi Zhang; Sahara J Cathcart; Dominick J DiMaio; Michael Punsoni; Bingjie Guan; Ping Zhou; Shuo Wang; Surinder K Batra; Tatiana Bronich; Tom K Hei; Chi Lin; Chi Zhang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.